Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall
- PMID: 2476993
- DOI: 10.1016/0021-9150(89)90223-2
Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall
Abstract
S-protein/vitronectin is a multifunctional glycoprotein interacting with both complement activation and coagulation pathways. Its presence was investigated in 5 femoral and 5 iliac atherosclerotic human arteries, obtained at surgery, by immunoelectron microscopy using an affinity purified rabbit IgG specific for human S-protein/vitronectin. The immunoelectron dense specific deposits were found in both intimal thickenings and fibrous plaques in association with elastic fibers, collagen bundles and cell debris in the vicinity of elastin. Cell debris embedded in the collagen matrix were S-protein/vitronectin negative. S-protein/vitronectin was also absent on intact cells, lipid droplets and cholesterol clefts. All cell debris, however, was positive for C5b-9 deposits suggesting that complement activation had occurred at these sites with or without S-protein/vitronectin interaction. S-protein/vitronectin may play a role in the arterial wall defence by restricting the extent of complement activation.
Similar articles
-
Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque.Atherosclerosis. 1986 Jul;61(1):35-42. doi: 10.1016/0021-9150(86)90111-5. Atherosclerosis. 1986. PMID: 3524587
-
Cells carrying C5b-9 complement complexes in human atherosclerotic wall.Immunol Lett. 1989 Mar;20(4):305-10. doi: 10.1016/0165-2478(89)90039-4. Immunol Lett. 1989. PMID: 2714850
-
Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis.Atherosclerosis. 1987 May;65(1-2):1-11. doi: 10.1016/0021-9150(87)90002-5. Atherosclerosis. 1987. PMID: 2955791
-
The role of connective tissue in atherosclerosis.Adv Exp Med Biol. 1978;109:155-94. doi: 10.1007/978-1-4684-0967-3_9. Adv Exp Med Biol. 1978. PMID: 364945 Review. No abstract available.
-
[Vitronectin in normal human skin and in skin lesions].Hautarzt. 1991 Jan;42(1):16-22. Hautarzt. 1991. PMID: 1707041 Review. German.
Cited by
-
Detection of vitronectin mRNA in tissues and cells of the mouse.Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9402-6. doi: 10.1073/pnas.88.21.9402. Proc Natl Acad Sci U S A. 1991. PMID: 1719529 Free PMC article.
-
Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin.Mol Neurodegener. 2008 Oct 21;3:16. doi: 10.1186/1750-1326-3-16. Mol Neurodegener. 2008. PMID: 18939994 Free PMC article.
-
Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.J Cell Biol. 1990 Sep;111(3):1283-91. doi: 10.1083/jcb.111.3.1283. J Cell Biol. 1990. PMID: 1697297 Free PMC article.
-
The role of complement activation in atherosclerosis.Immunol Res. 2004;30(1):73-80. doi: 10.1385/IR:30:1:073. Immunol Res. 2004. PMID: 15258311 Review.
-
Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.J Clin Invest. 1997 Jul 1;100(1):58-67. doi: 10.1172/JCI119521. J Clin Invest. 1997. PMID: 9202057 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources